Towards an optimum strategy in rheumatoid arthritis

Lancet. 2012 May 5;379(9827):1682-4. doi: 10.1016/S0140-6736(12)60164-0. Epub 2012 Mar 29.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antirheumatic Agents / administration & dosage*
  • Arthritis, Rheumatoid / drug therapy*
  • Biological Therapy*
  • Female
  • Humans
  • Infliximab
  • Male
  • Methotrexate / therapeutic use*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Methotrexate